JonesTrading Institutional Services (JonesTrading), a specialist in equity research for the healthcare, financial services and energy sectors, has added Justin Walsh PhD and Sean Kim PhD to its healthcare team.

Walsh will be covering biotechnology companies within the Healthcare sector. Before joining JonesTrading, he was a Research Analyst at B Riley Securities covering SMID cap biotechnology and healthcare companies with a primary focus on oncology. Earlier, he contributed to the coverage of a diverse set of biotechnology companies as an equity research associate at JMP Securities and Raymond James & Associates. He earned his PhD in chemistry from Hunter College and the City University of New York Graduate Center, wherein he collaborated with Memorial Sloan Kettering Cancer Center to study next-generation cancer imaging approaches. He holds a BA in chemistry and mathematics from Rollins College.

Kim will be covering biotechnology companies within the Healthcare sector. Before joining JonesTrading, Kim was a Senior Research Associate at Mizuho Securities, covering large cap US pharmaceuticals and SMID cap biotechnology companies. Previously, he worked as a research scientist for a number of biotechnology companies including Gilead Sciences and Nektar Therapeutics, and served as a faculty member in the School of Pharmacy at the University of Pittsburgh. He earned his PhD in Bioengineering from the University of California, Berkeley and San Francisco, and a BA in Mathematics and Computer Science from the University of California, Berkeley. He also completed his MBA at Haas School of Business, University of California, Berkeley.